The neural crest is a multipotent population of cells that arises at the neural plate border in the vertebrate embryo. We have previously shown that a member of the Sox family of transcription factors, Sox9, is a regulator of neural crest formation in Xenopus, as Sox9-depleted embryos failed to form neural crest progenitors. Here, we describe experiments that further investigate Sox9 function during neural crest development. Induction of neural crest progenitors in Xenopus is regulated by Wnt signaling. We show that this process is largely dependent on Sox9 function as Wnt-mediated neural crest induction is inhibited in the context of Sox9-depleted embryos. Moreover, we demonstrate that Sox9 functions as a transcriptional activator during neural crest formation. Expression of a construct in which Sox9 DNA-binding domain (HMG box) is fused to the repressor domain of Drosophila engrailed blocked neural crest formation, thereby mimicking the phenotype of Sox9-depleted embryos. Finally, using a hormone-inducible inhibitory mutant of Sox9, lacking the transactivation domain, we show that Sox9 function is required for neural crest specification but not for its subsequent migration.
Introduction
The neural crest is a population of multipotent cells unique to the vertebrate embryo. At the end of gastrulation, the neural crest arises at the junction between the nonneural ectoderm and the neural plate. Later, as the plate folds into a tube, these cells will leave the dorsal portion of the neuroepithelium and migrate throughout the embryo to give rise to a wide variety of cell types (reviewed in LeDouarin and Kalcheim, 1999) . The neural crest contributes cartilage, bone, and connective tissue to the face, neurons, and glial cells to the peripheral nervous system, pigment cells to the skin, as well as mesenchyme and smooth muscle cells to the cardiovascular system. Therefore, defects in the specification, migration, or differentiation of neural crest cells can have dramatic consequences on many different organ systems (Bolande, 1997) .
Several transcriptional regulators have been implicated in the formation of the neural crest initially based on their expression in the neural crest-forming region in different species (reviewed in Gammill and Bronner-Fraser, 2003) . In Xenopus, such factors include Twist (Hopwood et al., 1985) , Snail (Essex et al., 1993) , Slug (Mayor et al., 1995) , Zic3 (Nakata et al., 1997) , Pax3 (Bang et al., 1997) , Msx1 (Suzuki et al., 1997) , Ets-1 (Meyer et al., 1997) , Meis1b (Maeda et al., 2001) , Zic5 (Nakata et al., 2000) , FoxD3 0012-1606/$ -see front matter D 2004 Elsevier Inc. All rights reserved. doi:10.1016/j.ydbio.2004.07.036 (Sasai et al., 2001) , Sox9 (Spokony et al., 2002) , AP2 (Luo et al., 2003) , Nbx (Kurata and Ueno, 2003) , Sox10 (Aoki et al., 2003; Honore et al., 2003) , and cMyc (Bellmeyer et al., 2003) . While these factors have overlapping expression domains within the neural crest, it is not clear whether all cells at the neural plate border express the same repertoire of genes. Interestingly, a number of these transcription factors have the ability to mutually crossregulate their expression (Aoki et al., 2003; Sasai et al., 2001) , suggesting that they might be reciprocally involved in maintaining each other's expression. This characteristic has made it very difficult to establish a clear hierarchy in the genetic cascade leading to neural crest specification.
With the exception of the transcriptional repressors Slug and Snail that have been implicated in the control of neural crest specification and migration in Xenopus Carl et al., 1999; LaBonne and Bronner-Fraser, 2000) , very little is known about the precise mechanism of action of the other factors expressed at the neural plate border and the way in which they regulate neural crest development.
We have previously shown that the Sox family member Sox9 is required for neural crest formation in Xenopus using a morpholino-mediated bknockdownQ of Sox9 protein (Spokony et al., 2002) . However, this study did not directly address the specifics of Sox9 function at the neural plate border. Is Sox9 required for neural crest induction mediated by Wnt signaling, a well-established neural crest-inducing signal? Is Sox9 acting as a transcriptional activator in the context of the neural crest as it does during chondrocyte development Ng et al., 1997) , or as a repressor like other neural crestspecific transcription factors Kurata and Ueno, 2003; LaBonne and Bronner-Fraser, 2000; Sasai et al., 2001) ? Is Sox9 required for both specification of the neural crest and its subsequent migration similar to the Snail-related factors Carl et al., 1999; LaBonne and Bronner-Fraser, 2000) ? Here, we describe experiments that answer these questions and thereby further define Sox9 function in the developing neural crest.
Materials and methods

Constructs
Xenopus Sox9 DNA-binding domain (HMG box), aa 130-182, was generated by PCR and cloned into XhoI site of CS2+VP16-N and CS2+Eng-N (Kessler, 1997) . These constructs are referred as Sox9-VP16 and Sox9-Eng, respectively. An inhibitory mutant of Sox9 (Sox9DC), in which the C-terminal domain of Sox9 cDNA is deleted at position 311aa, was generated by PCR, and a hormoneinducible construct was generated by fusing Sox9DC to the coding region of the human glucocorticoid receptor ligandbinding domain (GR) as described (Gammill and Sive, 1997; Tada et al., 1997) . This fusion construct cloned into pCS2+ is referred as Sox9DC-GR (Saint-Germain et al., 2004) . A dominant-negative Slug construct (D-Slug) lacking the amino-terminal domain was generated by PCR as described (LaBonne and Bronner-Fraser, 2000) and cloned into pCS2+ vector (Aoki et al., 2003) . All constructs were sequenced, and the corresponding proteins were monitored using an in vitro transcription/translation coupled rabbit reticulocyte lysate system in the presence of [ 35 S]methionine (Promega) and resolved on a NuPAGE BIS-Tris gel (Invitrogen).
Western blot analysis
In vitro transcription/translation was performed in the presence of unlabeled methionine and resolved on a NuPAGE BIS-Tris gel. The gel was blotted onto nitrocellulose and incubated in the presence of a pan-Sox antibody (CeMines, Evergreen, CO; AB/HMG4), at a 1:1000 dilution. This antibody commercialized as a bSox10-specific antibodyQ cross-react with several Sox proteins, including Sox2, Sox8, and Sox9 (not shown), as the antibody was raised against a portion of Sox10 HMG box, highly conserved among several Sox family members. After extensive washes, the blot was incubated with antirabbit Ig coupled to horseradish peroxidase (Amersham Pharmacia Biotech, 1:60,000 dilution). The product of the reaction was revealed using the SuperSignal West Femto Maximum Sensitivity Substrate from Pierce and detected by exposure onto a BioMax film (Kodak).
Injections and dexamethasone treatment
Xwnt-3A (0.1 ng; Wolda et al., 1993) , noggin (0.2 ng; Smith and Harland, 1992) , Sox9-Eng (0.4 ng), Sox9-VP16 (0.4 ng), Sox9DC-GR (1 ng; Saint-Germain et al., 2004) , and DSlug (1-2 ng; Aoki et al., 2003; LaBonne and Bronner-Fraser, 2000) mRNAs were synthesized in vitro using the Message Machine kit (Ambion, Austin, TX). Sox9 morpholino antisense (Sox9-AS, 10 ng, Spokony et al., 2002) and control morpholinos, a fivebase pair mismatched Sox9 morpholino (Saint-Germain et al., 2004) , or a standard control morpholino (Co-AS, 10 ng) were obtained from GeneTools (Corvallis, OR). Synthetic mRNAs, plasmid DNA, and morpholinos were injected in one blastomere at the two-cell stage. For plasmid injections, Xwnt-1 (0.1 ng) and Xwnt-3A (0.1 ng) cloned into CS2+ were used (Saint-Jeannet et al., 1997) . In all experiments, embryos were coinjected with h-galactosidase mRNA (h-gal, 1 ng) as a lineage tracer. Embryos injected with Sox9DC-GR mRNA were treated at different time points (stage 6, 8, 10, 12, 14, 17, 20, or 22; Nieuwkoop and Faber, 1967) with 10 AM of dexamethasone (Sigma) in 0.1Â NAM as described (Aoki et al., 2003; Gammill and Sive, 1997; Saint-Germain et al., 2004; Tada et al., 1997) . Embryos at stages 15/17 or 25 were fixed in MEMFA (Harland, 1991) and successively processed for Red-Gal (Research Organics) staining and in situ hybridization.
Whole-mount in situ hybridization
Antisense DIG-labeled probes (Genius kit, Roche) were synthesized using template cDNA encoding Slug (Mayor et al., 1995) , Snail (Essex et al., 1993) , AP2 (Luo et al., 2003) , Pax3 (Bang et al., 1997) , Twist (Hopwood et al., 1985) , Sox2 (Mizuseki et al., 1998 ), or Sox10 (Aoki et al., 2003 . Whole-mount in situ hybridization was performed as described (Harland, 1991) .
Analysis of gene expression by real-time RT-PCR
Both blastomeres of two-cell stage were injected in the animal pole region with Xwnt-3A (0.1 ng), noggin (0.2 ng) and DSlug (2 ng) mRNAs, and 10 ng of morpholinos (Co-AS or Sox9-AS). Animal explants were dissected at the blastula stage and cultured in vitro until equivalent stage 17. Real-time RT-PCR (LightCycler, Roche) was performed using the following primers: EF-1a (forward primer: ACCCTCCTCTTGGTCGTTTT; reverse primer: TTTGGTTTTCGCTGCTTTCT; 134 nt), Slug (forward primer: CATGGGAATAAGTGCAACCA; reverse primer: AGGCACGTGAAGGGTAGAGA; 120 nt), Snail (forward primer: TCACAAAGGCAGTGCTTCAC; reverse primer: TTGTTCTCTGTGCCAACTGC; 116 nt), and Sox9 (forward primer: CACATTTGGGGAAAACTGCT; reverse primer: CCCTGTAAAAGGCAATGGAA; 103 nt). The cycle conditions were as follows: denaturation at 958C (4 s), annealing at 608C (9 s), and extension at 728C (14 s). By optimizing primers and reaction conditions, a single specific product was amplified as confirmed by melting curve analysis. Water blank and ÀRT reactions were also performed as negative controls. To quantify expression levels relative to control, serial dilutions of RNA extracted from Wnt-3A+noggin-injected explants were used as concentration standards in each real-time RT-PCR reaction. In each case, EF1a was used as a loading control (data not shown), and each bar on the histograms was normalized to the level of EF1a.
Results
Wnt-mediated neural crest induction depends on Sox9 function
Because Wnt signaling has been implicated in neural crest induction in several species (reviewed in Wu et al., 2003; Yanfeng et al., 2003) , we tested the requirement of Sox9 function for Wnt-mediated neural crest induction. To this end, we analyzed the ability of Wnt-1 and Wnt-3A to generate neural crest progenitors in the context of Sox9depleted embryos (Sox9-AS; Spokony et al., 2002) . Injection in one blastomere at the two-cell stage of plasmid DNA (used instead of RNA to avoid axis duplication) encoding Wnt-1 or Wnt-3A in combination with a control morpholino (Co-AS) resulted in a dramatic expansion of Slug and Snail expression domain in a large proportion of embryos ( Figs. 1A, B ). This phenotype is consistent with previous reports (Luo et al., 2003; Saint-Jeannet et al., 1997) . However, Wnt-1-or Wnt-3A-mediated Slug and Snail expansion was strongly inhibited, and in the most extreme cases, Slug and Snail expression was completely abolished, in the context of Sox9-depleted embryos (Figs.  1A, B ). The requirement of Sox9 for neural crest induction by Wnt signaling was also analyzed in the context of animal explants (Fig. 1C ). Wnt activation in conjunction with attenuation of bone morphogenetic protein (BMP) signaling can induce Slug, Snail, and Sox9 expression in animal explants (Fig. 1C; LaBonne and Bronner-Fraser, 1998; Luo et al., 2003; Saint-Jeannet et al., 1997) . We found that in the context of Sox9-depleted animal explants, coinjection of Wnt-3A and noggin failed to activate Slug and Sox9 expression (Fig. 1C ). The reduction in Sox9 expression in these explants is consistent with the observation that Sox9-AS can block Sox9 expression in whole embryo (not shown), indicating that Sox9 regulates its own expression. In contrast to these results Snail expression was not reduced in these explants, suggesting that Wnt-mediated Snail induction can occur independently of Sox9 function or that Snail and Slug/Sox9 respond to different levels of Sox9 protein. Moreover, the increase in Snail expression observed indicates that Sox9 may have a role in repressing Snail expression in this type of preparation.
Altogether, these results indicate that Sox9 function is implicated in Wnt-mediated neural crest induction in both the whole embryo and animal explants, thereby positioning Sox9 as a key regulator of neural crest specification, downstream of Wnt signaling. The difference in the regulation of Snail in the context of Sox9-depleted embryos and animal explants may suggest that other factors, absent in animal explants, contribute to the control of Snail expression in the whole embryo.
Regulation of Sox9 expression by Slug
We next analyzed the regulation of Sox9 and Snail by Slug. Injection of a dominant negative Slug mRNA, DSlug (Aoki et al., 2003; LaBonne and Bronner-Fraser, 2000) , resulted in a reduction of Slug (74%, n=62) and Sox9 (52%, n=63) expression ( Fig. 2A ; LaBonne and Bronner-Fraser, 2000) . In contrast, Snail expression was either unaffected (31%) or mildly expanded (52%) in these embryos (n=63; Fig. 2A ). The regulation of Sox9 and Snail by Slug was also analyzed in the context of animal explants (Fig. 2B ). We found that the injection of DSlug blocked Wnt-3a-mediated Slug and Sox9 induction in these explants, while Snail expression appeared to be increased (Fig. 2B) .
These results, together with the observation that Sox9 regulates Slug expression ( Fig. 1 ; Spokony et al., 2002) , indicate that Sox9 and Slug are likely to be involved in maintaining each other's expression. This type of reciprocal activation loops has also been implicated in the induction and maintenance of Zic-r1, FoxD3, Slug, and Sox10 expression (Aoki et al., 2003; Sasai et al., 2001) . On the other hand, unlike Slug and Sox9, Snail is not reduced in these experiments, suggesting that Snail is probably acting upstream of Slug in the genetic cascade leading to neural crest formation as previously proposed . The increase in Snail expression is likely to be an indirect consequence of DSlug-mediated Sox9 reduction, thereby preventing Sox9 inhibitory activity on Snail (Fig. 1C ).
Sox9 functions as a transcriptional activator during neural crest formation
We next analyzed the nature of the transcriptional activity of Sox9 in the context of the developing neural crest. The well-characterized regulatory domains of the herpes simplex virus VP16 activator and the Drosophila engrailed repressor were fused to Sox9-HMG box ( Fig. 2A ; Sox9-VP16 and Sox9-Eng constructs, respectively). By Western blot analy- While Snail remains unaffected. Explants were harvested and analyzed at equivalent stage 17. In each experiment, EF1a is used as a loading control (data not shown), and each result is normalized to the expression of EF1a. Values (n = 3) are presented as mean F SEM. *P b 0.05 versus noggin+Wnt-3A; **P b 0.1 versus noggin+Wnt-3A. Single injection of DSlug had no effect on the expression of these genes (not shown). sis, a pan-Sox antibody recognized a single product in transcription/translation reactions directed by Sox9, Sox9-Eng, and Sox9-VP16 cDNAs (Fig. 3B ). The activity of these fusion proteins was subsequently tested for their ability to affect formation of cells at the neural plate border as determined by Slug, Snail, Sox10, and Sox2 expression at stages 15/17. Our results indicate that injection of the repressor domain fusion, Sox9-Eng, blocks Slug, Snail, and Sox10 neural crest expression while expanding the expression domain of the neural plate marker Sox2 (Fig. 3C) , thereby replicating the phenotype of Sox9-depleted embryos (Fig. 2B , Sox9-AS; Spokony et al., 2002) . However, because the HMG box is very highly conserved among Sox proteins of the E subgroup, we cannot exclude the possibility that Sox9-Eng fusion may also interfere with Sox8 and Sox10 function in these embryos.
In contrast, injection of the activator domain fusion, Sox9-VP16, had very little effect on the expression of Slug, Snail, Sox10, and Sox2. Since overexpression of wild-type Sox9 leads to a moderate expansion of Slug and Sox10 expression domain (Aoki et al., 2003; Spokony et al., 2002) , the lack of activity of Sox9-VP16 may suggest that domains outside the HMG box might be needed in addition to the transactivation domain to fully recapitulate the activity of wild-type Sox9. Alternatively, the VP16 domain used in this study may not be a strong enough activator to mimic Sox9 gain-of-function phenotype.
We propose that Sox9 acts as a transcriptional activator in the neural crest-forming region. This result implies that putative downstream targets of Sox9 should be up-regulated during neural crest formation.
Sox9 is required for neural crest specification
Our previous work indicated that Sox9 is required for neural crest formation (Spokony et al., 2002) . To further define the window of time during which Sox9 is functioning for neural crest development, we generated an inducible inhibitory mutant Sox9 construct (Sox9DC-GR) in which the hormone-binding domain of the human glucocorticoid receptor is fused to a form of Sox9 lacking the transactivation domain ( Fig. 4A ; Saint-Germain et al., 2004) . Embryos were injected in one blastomere at the two-cell stage with 1 ng of Sox9DC-GR mRNA and treated with dexamethasone at various stages (Fig. 4B ).
Addition of dexamethasone at the blastula stages (stage 6 or 8) caused a loss of expression of Slug, Pax3, and to a lesser extent AP2 at stage 17 (Figs. 4C, D) . This result is consistent with the phenotype of Sox9-depleted embryos previously described (Spokony et al., 2002) and suggests that this fusion construct is fully active in blocking Sox9 function. Dexamethasone treatment at the gastrula stage (+Dex stage 10 or 12) also resulted in a similar loss of all three neural crest markers (Figs. 4C, D) . However, inactivation of Sox9 at the neurula stage (+Dex stage 14) failed to block Slug, Pax3, and AP2 expression in the neural crest-forming region (Figs. 4C, D) . As a control, injections of GR mRNA had no effect on endogenous Slug, Pax3, and AP2 expression after addition of dexamethasone (not shown).
These results indicate that Sox9 function is required before stage 14 to specify the neural crest, consistent with the timing of neural crest induction in Xenopus.
Sox9 is not required for cranial neural crest migration
Once specified, neural crest cells delaminate in a rostrocaudal wave and migrate throughout the embryo.
To determine whether Sox9 is also required for subsequent migration of the neural crest cells, we analyzed the pattern of expression of AP2 and Twist in the migrating cranial neural crest of stage 25 embryos in which Sox9 had been inactivated before neural crest migration (stage 17) or during the early phase of migration, stage 20, and stage 22 (Sadaghiani and Thiebaud, 1987) , thereby bypassing the early requirement for Sox9 in neural crest specification (Fig. 5A ). All embryos treated with dexamethasone at stage 17 (n = 52, AP2 and n = 59, Twist), stage 20 (n = 59, AP2 and n = 44, Twist), or stage 22 (n = 52, AP2 and n = 60, Twist) developed a normal pattern of migrating cranial neural crest at stage 25 (Fig. 5B ). By Western blot analysis, the levels of Sox9DC-GR protein remained constant throughout development (not shown; Saint-Germain et al., 2004) , and therefore the lack of activity at these later stages cannot be attributed to a reduced accumulation of the fusion protein.
These experiments indicate that while Sox9 is required for specification of the neural crest, their subsequent migration into the branchial arches can occur independently of Sox9 function. (Sox2) markers at stage 15/17. Sox9-Eng construct blocks expression of the neural crest markers Slug, Snail, and Sox10 and expands the neural plate-specific gene Sox2, thereby mimicking the phenotype of Sox9-depleted embryos (Sox9-AS). RNA encoding the lineage tracer h-galactosidase was coinjected to identify the injected side (red staining, left side in all panels, arrows). Embryos are viewed from the dorsal side, anterior to the top. In each panel, the number of embryos analyzed is indicated in the lower right corner (n=), and the percentage of embryos exhibiting the phenotype shown is indicated in the upper right corner.
Discussion
In this study, we present evidence that the transcriptional activator Sox9 is strictly required for specification of the neural crest in Xenopus, downstream of Wnt signaling. This is supported by several observations: (i) Wnt-mediated neural crest induction is largely inhibited in the context of Sox9-depleted embryos and animal explants; (ii) expression of a chimeric Sox9-repressor protein blocks neural crest formation, mimicking the phenotype of Sox9-depleted embryos; and (iii) temporal inactivation of Sox9 using a hormone-inducible inhibitory mutant demonstrates that Sox9 is required for specification of the neural crest but not its subsequent migration.
Neural crest specification is believed to depend on multiple signals emanating from the nonneural ectoderm and/or the paraxial mesoderm. Such factors include members of the bone morphogenetic protein (BMP), fibroblast growth factor (FGF), and Wnt families (reviewed in Knecht and Bronner-Fraser, 2002; LaBonne and Bronner-Fraser, 1999) . The involvement of Wnt signaling in neural crest induction has been especially well documented in several species (reviewed in Wu et al., 2003; Yanfeng et al., 2003) . Using a morpholino-mediated bknockdownQ of Sox9 pro-tein, we show that Wnt-mediated Slug induction depends on Sox9 function in the whole embryo and in neuralized animal explants. This observation, together with the fact that ectopic Wnt expression enhances, and lack of Wnt signaling inhibits, the neural crest expression of both Sox9 and Slug (Luo et al., 2003) , suggests that Sox9 is required upstream of Slug in the genetic cascade leading to neural crest formation. This view is consistent with the fact that Sox9 expression precedes that of Slug at the neural plate border; Sox9 expression is initiated at stage 12 (Spokony et al., 2002) , while Slug is only detectable by stage 12.5 Linker et al., 2000; Mayor et al., 1995) . However, the Xenopus Slug promoter contains a functional Tcf/Lef binding site, indicating that Wnt signaling can also Fig. 4 . Sox9 is required for neural crest induction. (A) Schematic representation of the hormone-inducible inhibitory mutant Sox9 construct. Sox9 lacking the transactivation domain (Sox9DC) is fused to the ligand-binding domain of human glucocorticoid receptor (hGR, purple). (B) Experimental timeline. Two-cell stage embryos are injected in one blastomere with 1 ng of Sox9DC-GR mRNA. Embryos are subsequently incubated with dexamethasone (+DEX) at different time point during development (stages 6, 8, 10, 12, or 14) , and fixed at stage 17 for detection of Slug, Pax3, or AP2 by whole-mount in situ hybridization. (C) Whole-mount in situ hybridization of embryos injected in one blastomere at the two-cell stage with 1 ng of Sox9DC-GR mRNA and treated with dexamethasone (+DEX) at the gastrula (stage 10) or neurula (stage 14) stages. Embryos were analyzed for expression of three early neural crest markers (Slug, Pax3, and AP2) at stage 15/17. Activation of Sox9 inhibitory mutant (Sox9DC-GR) before stage 14 blocks formation of neural crest progenitors. RNA encoding the lineage tracer h-galactosidase was coinjected to identify the injected side (red staining, left side in all panels, arrows). Embryos are viewed from the dorsal side, anterior to the top. (D) Quantification of Slug, Pax3, and AP2 in situ hybridization results. The numbers at the top of each bar indicate the number of cases analyzed. Slug (red bars) and Pax3 (blue bars) expressions were analyzed after treatment with dexamethasone at five time points, stages 6, 8, 10, 12, and 14. AP2 expression (green bars) was analyzed after treatment with dexamethasone at three time points, stages 6, 10, and 14.
activate Slug directly (Vallin et al., 2001) . So far, there is no evidence that the Sox9 promoter contains a similar Tcf/Lef binding site, but our results predict this possibility. Therefore, we would like to suggest that Wnt-mediated Slug induction can occur through both a Sox9-dependent and a Sox9-independent pathway.
Sox9 has the capability to regulate its own expression (not shown; Fig. 1C ), similar to Slug (LaBonne and Bronner-Fraser, 2000; Fig. 2A,B) . Additionally, Slug and Sox9 can mutually regulate their expression in a manner suggesting that they may be involved in maintaining each other's expression ( Fig. 2A ; Aoki et al., 2003) . This type of reciprocal activation loops makes it difficult to separate the induction of a gene from its maintenance in the context of some of the experiments described here.
Recently, it has been proposed that Snail precedes Slug in the regulatory pathway leading to neural crest formation . Using a dominant negative Slug, we also found that Snail expression can be regulated independently from Slug in whole embryos and animal explants (Fig.  2) . The onset of Snail expression in the prospective neural crest has been reported at stage 11 , before Sox9 expression, suggesting that Snail may also act upstream of Sox9 during neural crest formation. This is consistent with the view that Wnt-mediated Snail induction in animal explants can occur in the absence of Sox9 function. However, this does not appear to be the case in whole embryos where endogenous Snail expression as well as Wnt-mediated Snail induction is blocked in Sox9depleted embryos. This apparent discrepancy may reflect a higher level of complexity in the regulation of genes in the context of the developing embryo.
While the majority of the Sox proteins possess a classical activation domain (reviewed in Kamachi et al., 2000) , it is now well established that transcription factors can acquire repressor or activator activity in different developmental contexts. For example, this is the case for members of the TCF family and for the POU domain-containing proteins (Botquin et al., 1998; Roose and Clevers, 1999) . During cartilage differentiation, Sox9 has been shown to function as a transcriptional activator by binding and activating the chondrocyte-specific enhancer of collagen type II Bi et al., 1999; Ng et al., 1997) , but nothing is known about Sox9 transcriptional activity at the neural plate border. Expression of chimeric Sox9 constructs carrying the wellcharacterized regulatory domains of the herpes simplex virus VP16 activator or the Drosophila engrailed repressor fused to Sox9 HMG box allowed us to establish that Sox9 also behaves as a transcriptional activator in the context of the neural crest. The results presented here using the fusion constructs imply that Sox9 activates target genes in the neural crest-forming region. Sox9 is the first transcription factor expressed at the neural plate border reported to act as a transcriptional activator. Factors such as Slug, Snail, FoxD3, and Nbx have all been shown to act as transcriptional repressors Kurata and Ueno, 2003; LaBonne and Bronner-Fraser, 2000; Sasai et al., 2001) . The activation of neural crest markers observed upon Slug, Snail, FoxD3, or Nbx overexpression is therefore likely to be indirect, presumably through repression of an inhibitor of neural crest fate.
A number of studies have established Sox9 as a regulator of neural crest formation in frog (Spokony et al., 2002) , chick (Cheung and Briscoe, 2003) , and mouse (Mori-Akiyama et al., 2003) . To further define the window of time during which Sox9 is functioning during neural crest formation, we generated a hormone-inducible inhibitory Sox9 construct (Sox9DC-GR) to produce a temporal inactivation of Sox9 function. We show that inactivation (stages 17, 20, or 22) , and fixed at stage 25 for detection of Twist and AP2 in the migrating cranial neural crest by whole-mount in situ hybridization. (B) AP2 and Twist whole-mount in situ hybridization of such embryos. Activation of Sox9 inhibitory mutant (+Dex) after neural crest specification (stage 17 or 22) does not prevent cranial neural crest cell migration. Note that the extent of migration of AP2-and Twist-expressing cells in the cranial region is identical in control (uninjected) and injected sides. RNA encoding the lineage tracer h-galactosidase was coinjected to identify the injected side (red staining). Embryos are viewed from the lateral side, anterior to the right (left panels) or anterior to the left (right panels). of Sox9 during gastrulation (stages 6-12) prevented Slug, Pax3, or AP2 expression, while inactivation of Sox9 at the neural plate stage (stage 14) had no effect on the expression of these markers. The percentage of embryos with reduced neural crest markers (Slug and AP2) was higher in the context of dexamethasone treatment performed at stage 10 than at stage 6. This difference may indicate that factors other than Sox9 are involved in inducing neural crest at earlier stages or that the inactivation of Sox9 closer to the time at which neural crest is normally induced can generate a stronger phenotype. Altogether, these observations indicate that a Sox9-dependent pathway is required for specification of the neural crest and that the inductive events involved are taking place before the neural plate stage, consistent with the timing of neural crest induction in Xenopus. Conversely, inactivation of Sox9 during the phases of neural crest migration (stages 17, 20, and 22), which bypass the early requirement for Sox9, had no effect on the migration of neural crest in the branchial arches, based on Twist and AP2 expression. This result indicates that, unlike Slug and Snail that have been implicated in both neural crest specification and migration Carl et al., 1999; LaBonne and Bronner-Fraser, 2000) , Sox9 is strictly functioning during the initial stages of neural crest specification. However, the experiments described here address primarily the function of Sox9 during migration of the cranial neural crest; therefore, we cannot exclude the possibility that Sox9 might be involved in regulating the migration of a late emerging population of neural crest cells in the trunk region. Nevertheless, this seems unlikely, as Sox9 expression is down-regulated in the trunk region around stage 25 (Spokony et al., 2002) before neural crest migration at this axial level (Sadaghiani and Thiebaud, 1987) . While FoxD3 has been involved in establishing neural crest fate in frog and chick embryos (Dottori et al., 2001; Kos et al., 2001; Sasai et al., 2001) , its requirement for neural crest migration is not as firmly established. Gainof-function studies in the chick indicate that FoxD3 can promote the delamination and migration of neural crest cell from the dorsal neural tube (Dottori et al., 2001; Kos et al., 2001) .
In conclusion, our results demonstrate that Sox9 functions as a transcriptional activator, downstream of Wnt signaling, strictly to specify the neural crest. The mode of action of Sox9 is therefore quite distinct from that of most transcription factors expressed at the neural plate border. The identification of the transcriptional targets of Sox9 represents an essential step to further our understanding of the mechanisms involved in the induction of this important population of cells at the neural plate border.
